drugset / Trial / NCT00549146
Treatment Of Partial Reversible Chronic Obstructive Pulmonary Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
Relatively little information is available about the effects of salmeterol/fluticasone combination and fluticasone alone in COPD patients with a partial reversible pulmonary obstruction. The purpose of this study is to compare the effects of salmeterol/fluticasone combination with fluticasone alone delivered via Diskus/ACCUHALER inhaler in subjects with COPD on lung function over a 1 year period.
Timeline
- Start
- 2003-11
- Primary completion
- 2006-04
- Completion
- 2006-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone propionate | Other / unclassified | 250 ug | Inhaled |
| Subject | Fluticasone propionate | Other / unclassified | 500 ug | Inhaled |
| Subject | Salmeterol | Other / unclassified | 50 ug | Inhaled |